These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 32690261)
1. Synthesis and antibiofilm evaluation of 3-hydroxy-2,3-dihydroquinazolin-4(1H)-one derivatives against opportunistic pathogen Acinetobacter baumannii. Yang G; Cheng C; Xu GB; Tang L; Chua KL; Yang YY Bioorg Med Chem; 2020 Aug; 28(16):115606. PubMed ID: 32690261 [TBL] [Abstract][Full Text] [Related]
2. Quorum-sensing system in Acinetobacter baumannii: a potential target for new drug development. Saipriya K; Swathi CH; Ratnakar KS; Sritharan V J Appl Microbiol; 2020 Jan; 128(1):15-27. PubMed ID: 31102552 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and biofilm inhibition studies of 2-(2-amino-6-arylpyrimidin-4-yl)quinazolin-4(3H)-ones. Rasapalli S; Murphy ZF; Sammeta VR; Golen JA; Weig AW; Melander RJ; Melander C; Macha P; Vasudev MC Bioorg Med Chem Lett; 2020 Dec; 30(23):127550. PubMed ID: 32927027 [TBL] [Abstract][Full Text] [Related]
4. Effect of secondary metabolite of Actinidia deliciosa on the biofilm and extra-cellular matrix components of Acinetobacter baumannii. Tiwari V; Tiwari D; Patel V; Tiwari M Microb Pathog; 2017 Sep; 110():345-351. PubMed ID: 28705748 [TBL] [Abstract][Full Text] [Related]
5. 5-Episinuleptolide Decreases the Expression of the Extracellular Matrix in Early Biofilm Formation of Multi-Drug Resistant Acinetobacter baumannii. Tseng SP; Hung WC; Huang CY; Lin YS; Chan MY; Lu PL; Lin L; Sheu JH Mar Drugs; 2016 Jul; 14(8):. PubMed ID: 27483290 [TBL] [Abstract][Full Text] [Related]
6. Disruption of biofilm formation by the human pathogen Acinetobacter baumannii using engineered quorum-quenching lactonases. Chow JY; Yang Y; Tay SB; Chua KL; Yew WS Antimicrob Agents Chemother; 2014; 58(3):1802-5. PubMed ID: 24379199 [TBL] [Abstract][Full Text] [Related]
7. Methoxy-Substituted Hydroxychalcone Reduces Biofilm Production, Adhesion and Surface Motility of Acinetobacter baumannii by Inhibiting ompA Gene Expression. Ušjak D; Dinić M; Novović K; Ivković B; Filipović N; Stevanović M; Milenković MT Chem Biodivers; 2021 Jan; 18(1):e2000786. PubMed ID: 33188577 [TBL] [Abstract][Full Text] [Related]
8. Octopromycin: Antibacterial and antibiofilm functions of a novel peptide derived from Octopus minor against multidrug-resistant Acinetobacter baumannii. Rajapaksha DC; Jayathilaka EHTT; Edirisinghe SL; Nikapitiya C; Lee J; Whang I; De Zoysa M Fish Shellfish Immunol; 2021 Oct; 117():82-94. PubMed ID: 34311097 [TBL] [Abstract][Full Text] [Related]
9. Cationic antimicrobial peptide and its poly-N-substituted glycine congener: Antibacterial and antibiofilm potential against A. baumannii. Sharma D; Choudhary M; Vashistt J; Shrivastava R; Bisht GS Biochem Biophys Res Commun; 2019 Oct; 518(3):472-478. PubMed ID: 31443965 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of Virulence Factors and Biofilm Formation of Acinetobacter Baumannii by Naturally-derived and Synthetic Drugs. Bamunuarachchi NI; Khan F; Kim YM Curr Drug Targets; 2021; 22(7):734-759. PubMed ID: 33100201 [TBL] [Abstract][Full Text] [Related]
11. Biofilm Formation Caused by Clinical Acinetobacter baumannii Isolates Is Associated with Overexpression of the AdeFGH Efflux Pump. He X; Lu F; Yuan F; Jiang D; Zhao P; Zhu J; Cheng H; Cao J; Lu G Antimicrob Agents Chemother; 2015 Aug; 59(8):4817-25. PubMed ID: 26033730 [TBL] [Abstract][Full Text] [Related]
12. A Novel Genetic Determination of a Lectin Gene in Iraqi Muslim SN; Al-Kadmy IMS; Auda IG; Mohammed Ali AN; Al-Jubori SS J AOAC Int; 2018 Sep; 101(5):1623-1630. PubMed ID: 29618401 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of 4,5-disubstituted-2-aminoimidazole-triazole conjugates for antibiofilm/antibiotic resensitization activity against MRSA and Acinetobacter baumannii. Su Z; Peng L; Worthington RJ; Melander C ChemMedChem; 2011 Dec; 6(12):2243-51. PubMed ID: 21928438 [TBL] [Abstract][Full Text] [Related]
14. Characterizing the Antimicrobial Activity of Fleeman R; Van Horn KS; Barber MM; Burda WN; Flanigan DL; Manetsch R; Shaw LN Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28289036 [TBL] [Abstract][Full Text] [Related]
15. Clinical isolates of Acinetobacter baumannii from a Portuguese hospital: PFGE characterization, antibiotic susceptibility and biofilm-forming ability. Duarte A; Ferreira S; Almeida S; Domingues FC Comp Immunol Microbiol Infect Dis; 2016 Apr; 45():29-33. PubMed ID: 27012918 [TBL] [Abstract][Full Text] [Related]
16. Antibiofilm and antivirulence efficacy of myrtenol enhances the antibiotic susceptibility of Acinetobacter baumannii. Selvaraj A; Valliammai A; Sivasankar C; Suba M; Sakthivel G; Pandian SK Sci Rep; 2020 Dec; 10(1):21975. PubMed ID: 33319862 [TBL] [Abstract][Full Text] [Related]
17. Anti-biofilm and anti-virulence effects of zerumbone against Kim HR; Shin DS; Jang HI; Eom YB Microbiology (Reading); 2020 Aug; 166(8):717-726. PubMed ID: 32463353 [No Abstract] [Full Text] [Related]
18. Activity of Norspermidine on Bacterial Biofilms of Multidrug-Resistant Clinical Isolates Associated with Persistent Extremity Wound Infections. Cardile AP; Woodbury RL; Sanchez CJ; Becerra SC; Garcia RA; Mende K; Wenke JC; Akers KS Adv Exp Med Biol; 2017; 973():53-70. PubMed ID: 27864804 [TBL] [Abstract][Full Text] [Related]